Clinical Trial Update: Aflibercept Compared to Placebo in Term of Efficacy in Patients Treated With Gemcitabine for Metastatic Pancreatic Cancer [Phase 3]

View source ↗

Summary

A phase 3 trial evaluating aflibercept added to gemcitabine versus placebo with gemcitabine in metastatic pancreatic cancer was terminated; results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Zaltrap (ramucirumab)

Snippet

Sponsor: Sanofi | Conditions: Pancreatic Neoplasm | Phase 3 | Status: TERMINATED | Results posted: 2012-09-25